Maryam Sedghi

Maryam Sedghi


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Advanced Biomedical Research
Verified
Journal Article
Open access
PDF file
MSMaryam Sedghi
Maryam Sedghi
NNNayereh Nouri
Nayereh Nouri
EFEsmat Fazel-Najafabadi
Esmat Fazel-Najafabadi
MSMansoor Salehi
Mansoor Salehi
MHMajid Hosseinzadeh
Majid Hosseinzadeh
MGMohammadReza Ghazavi
MohammadReza Ghazavi
Background: The Duchenne muscular dystrophy (DMD) gene is located in the short arm of the X chromosome (Xp21). It spans 2.4 Mb of the human genomic DNA and is composed of 79 exons. Mutations in the Dystrophin gene result in DMD and Becker muscular dystrophy. In this study, the efficiency of multiplex ligation-dependent probe amplification (MLPA) over multiplex polymerase chain reaction (PCR) assays in an Iranian population was investigated. Materials and Methods: Multiplex PCR assays and MLPA analysis were carried out in 74 patients affected with DMD. Results: Multiplex PCR detected deletions in 51% of the patients with DMD. MLPA analysis could determine all the deletions detected by the multiplex PCR. Additionally, MLPA was able to identify one more deletion and duplication in patients without detectable mutations by multiplex PCR. Moreover, MLPA precisely determined the exact size of the deletions. Conclusion: Although MLPA analysis is more sensitive for detection of deletions and duplications in the dystrophin gene, multiplex PCR might be used for the initial analysis of the boys affected with DMD in the Iranian population as it was able to detect 95% of the rearrangements in patients with DMD.

20 February 2014 in Journal of Child Neurology
Verified
Journal Article
Closed access
HGHamid Ganji
Hamid Ganji
NNNayereh Nouri
Nayereh Nouri
MSMansoor Salehi
Mansoor Salehi
OAOmid Aryani
Omid Aryani
MHMassoud Houshmand
Massoud Houshmand
MSMaryam Sedghi
Maryam Sedghi
Proximal spinal muscular atrophy is an autosomal recessive disorder characterized by symmetrical muscle weakness due to degeneration of alpha motor neurons in the spinal cord. Homozygous deletions in the SMN1 have been reported in more than 90% of spinal muscular atrophy cases. Compound heterozygous patients account for approximately 4% of spinal muscular atrophy cases. In this study, we performed a quantitative test in 20 of 87 spinal muscular atrophy patients who did not have homozygous deletion of SMN1. Mutation screening of SMN1 gene was performed in 4 patients who have only 1 copy of SMN1 to identify intragenic mutations. In addition to a previously described missense mutation in exon 4 (p.A188S/ c.562G>T), we identified 2 novel mutations including a single nucleotide insertion in exon 7 (c.861_862insT/p.R288X) and a deletion of nucleotide G in exon 3 (c.286delG/p.D96Tfs*53). Our results suggested that about 4% of spinal muscular atrophy patients have subtle mutations and might be considered in laboratory examination.

1 December 2015 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
EFEsmat Fazel-Najafabadi
Esmat Fazel-Najafabadi
EAElham Vahdat Ahar
Elham Vahdat Ahar
SFShirin Fattahpour
Shirin Fattahpour
MSMaryam Sedghi
Maryam Sedghi

1 February 2014 in Gene
Verified
Journal Article
Closed access
NNNarges Nouri
Narges Nouri
EFEsmat Fazel-Najafabadi
Esmat Fazel-Najafabadi
MBMahdieh Behnam
Mahdieh Behnam
NNNayereh Nouri
Nayereh Nouri
OAOmid Aryani
Omid Aryani
MSMaryam Sedghi
Maryam Sedghi

14 November 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
HMHamidreza Mianesaz
Hamidreza Mianesaz
SGSafoura Ghalamkari
Safoura Ghalamkari
MSMansoor Salehi
Mansoor Salehi
MBMahdiyeh Behnam
Mahdiyeh Behnam
MHMajid Hosseinzadeh
Majid Hosseinzadeh
BABehnaz Ansari
Behnaz Ansari
Background: Limb‐girdle muscular dystrophy (LGMD) is a non‐syndromic muscular dystrophy caused by variations in the genes involved in muscle structure, function and repair. The heterogeneity in the severity, progression, age of onset, and causative genes makes next‐generation sequencing (NGS) a necessary approach for the proper diagnosis of LGMD.Methods: In this article, 26 Iranian patients with LGMD criteria were diagnosed with disease variants in the genes encoding calpain3, dysferlin, sarcoglycans and Laminin α‐2. Patients were referred to the hospital with variable distribution of muscle wasting and progressive weakness in the body. The symptoms along with biochemical and EMG tests were suggestive of LGMD; thus the genomic DNA of patients were investigated by whole‐exome sequencing including flanking intronic regions. The target genes were explored for the disease‐causing variants. Moreover, the consequence of the amino acid alterations on proteins' secondary structure and function was investigated for a better understanding of the pathogenicity of variants. Variants were sorted based on the genomic region, type and clinical significance.Results: In a comprehensive investigation of previous clinical records, 6 variations were determined as novel, including c.1354–2 A > T and c.3169_3172dupCGGC in DYSF, c.568 G > T in SGCD, c.7243 C > T, c.8662_8663 insT and c. 4397G > C in LAMA2. Some of the detected variants were located in functional domains and/or near to the post‐translational modification sites, altering or removing highly conserved regions of amino acid sequence.

1 August 2014
Verified
Open access
MBMahdiyeh Behnam
Mahdiyeh Behnam
SJShin Jin-Hong
Shin Jin-Hong
DKDae-Seong Kim
Dae-Seong Kim
KBKeivan Basiri
Keivan Basiri
YNYalda Nilipour
Yalda Nilipour
MSMaryam Sedghi
Maryam Sedghi
Hereditary inclusion body myopathy (hIBM) is an adult-onset hereditary myopathy, usually with distal onset and quadriceps sparing. This myopathy is autosomal recessive and associated to UPD-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE) gene mutations. In this study, we report a novel GNE homozygous point mutation c.1834T>G that results in amino acid substitution of cysteine 612 to glutamine in an Iranian patient. This mutation is located in exon 10 within the kinase domain of the protein.